Pfizer Picks Second TRL9 Candidate From Coley For Development In Oncology

Company will continue investigating compounds despite a recent setback with its Toll-like receptor program in lung cancer.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet